These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 18758039

  • 1. [PTH and mechanical stress].
    Fukumoto S.
    Clin Calcium; 2008 Sep; 18(9):1327-31. PubMed ID: 18758039
    [Abstract] [Full Text] [Related]

  • 2. [Hormones and osteoporosis update. Mechanisms of anabolic and catabolic effects of PTH on bone].
    Kobayashi T.
    Clin Calcium; 2009 Jul; 19(7):911-8. PubMed ID: 19567985
    [Abstract] [Full Text] [Related]

  • 3. [Anabolic action of PTH under the loading/unloading condition].
    Sakai A.
    Clin Calcium; 2012 Mar; 22(3):365-71. PubMed ID: 22370303
    [Abstract] [Full Text] [Related]

  • 4. [Parathyroid and bone. Effects of parathyroid hormone on bone resorption and formation: differences between intermittent and continuous treatment].
    Kaji H.
    Clin Calcium; 2007 Dec; 17(12):1836-42. PubMed ID: 18057658
    [Abstract] [Full Text] [Related]

  • 5. [Parathyroid and bone. The mechanism of anabolic function of parathyroid hormone on bone].
    Ogata N, Kawaguchi H.
    Clin Calcium; 2007 Dec; 17(12):1843-9. PubMed ID: 18057659
    [Abstract] [Full Text] [Related]

  • 6. Parathyroid hormone temporal effects on bone formation and resorption.
    Kroll MH.
    Bull Math Biol; 2000 Jan; 62(1):163-88. PubMed ID: 10824426
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Bone anabolic effects of parathyroid hormone are blunted by deletion of the Wnt antagonist secreted frizzled-related protein-1.
    Bodine PV, Seestaller-Wehr L, Kharode YP, Bex FJ, Komm BS.
    J Cell Physiol; 2007 Feb; 210(2):352-7. PubMed ID: 17044082
    [Abstract] [Full Text] [Related]

  • 9. [Parathyroid and bone. Role of parathyroid hormone in the treatment of osteoporosis].
    Nakamura T.
    Clin Calcium; 2007 Dec; 17(12):1823-9. PubMed ID: 18057656
    [Abstract] [Full Text] [Related]

  • 10. A new paradigm in the treatment of osteoporosis: Wnt pathway proteins and their antagonists.
    Chan A, van Bezooijen RL, Löwik CW.
    Curr Opin Investig Drugs; 2007 Apr; 8(4):293-8. PubMed ID: 17458178
    [Abstract] [Full Text] [Related]

  • 11. Current perspectives on parathyroid hormone (PTH) and PTH-related protein (PTHrP) as bone anabolic therapies.
    Esbrit P, Alcaraz MJ.
    Biochem Pharmacol; 2013 May 15; 85(10):1417-23. PubMed ID: 23500550
    [Abstract] [Full Text] [Related]

  • 12. Does osteocytic SOST suppression mediate PTH bone anabolism?
    Kramer I, Keller H, Leupin O, Kneissel M.
    Trends Endocrinol Metab; 2010 Apr 15; 21(4):237-44. PubMed ID: 20074973
    [Abstract] [Full Text] [Related]

  • 13. [Human parathyroid hormone (1-34) as a new therapeutic agent for osteoporosis].
    Isogai Y.
    Clin Calcium; 2005 Jan 15; 15(1):18-24. PubMed ID: 15632468
    [Abstract] [Full Text] [Related]

  • 14. [Therapeutic agents for disorders of bone and calcium metabolism--Parathyroid hormone in weekly subcutaneous injection].
    Uzawa T.
    Clin Calcium; 2007 Jan 15; 17(1):56-62. PubMed ID: 17211094
    [Abstract] [Full Text] [Related]

  • 15. Skeletal actions of intermittent parathyroid hormone: effects on bone remodelling and structure.
    Compston JE.
    Bone; 2007 Jun 15; 40(6):1447-52. PubMed ID: 17045858
    [Abstract] [Full Text] [Related]

  • 16. [Biological function of bone cells on the PTH-driven anabolic effect].
    Hasegawa T, Hongo H, Sasaki M, Yamada T, Amizuka N.
    Clin Calcium; 2012 Mar 15; 22(3):373-9. PubMed ID: 22370304
    [Abstract] [Full Text] [Related]

  • 17. Wnt signaling: a win for bone.
    Piters E, Boudin E, Van Hul W.
    Arch Biochem Biophys; 2008 May 15; 473(2):112-6. PubMed ID: 18364235
    [Abstract] [Full Text] [Related]

  • 18. [Secondary osteoporosis. Pathogenesis of glucocorticoid-induced osteoporosis].
    Takayanagi R.
    Clin Calcium; 2007 Feb 15; 17(2):270-4. PubMed ID: 17272886
    [Abstract] [Full Text] [Related]

  • 19. Parathyroid hormone enhances bone morphogenetic protein activity by increasing intracellular 3', 5'-cyclic adenosine monophosphate accumulation in osteoblastic MC3T3-E1 cells.
    Nakao Y, Koike T, Ohta Y, Manaka T, Imai Y, Takaoka K.
    Bone; 2009 May 15; 44(5):872-7. PubMed ID: 19442611
    [Abstract] [Full Text] [Related]

  • 20. Intermittent administration of human parathyroid hormone enhances bone formation and union at the site of cancellous bone osteotomy in normal and ovariectomized rats.
    Nozaka K, Miyakoshi N, Kasukawa Y, Maekawa S, Noguchi H, Shimada Y.
    Bone; 2008 Jan 15; 42(1):90-7. PubMed ID: 17997377
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.